GSK to Receive $320 Million as BioNTech and Pfizer Settle mRNA Patent Dispute with CureVac
One of the biggest developments in the ongoing mRNA patent dispute has arrived—GSK will receive $320 million following a settlement between the BioNTech, CureVac, and Pfizer dispute. The agreement, reached after BioNTech and Pfizer chose to end a high-profile legal battle with the German biotech CureVac, closes a multi-year dispute over mRNA vaccine technology. The […]
IP Litigation in India: Process, Laws, and How Disputes Are Resolved
With the growing awareness around Intellectual Property Rights (IPR), more investors and innovators are actively filing applications to protect their inventions and creations. This surge in registrations has naturally led to a rise in disputes, as overlapping claims and infringement cases become more frequent. In recent years, India has seen a sharp rise in intellectual […]
Global Patent Litigation Outlook 2024: Trends Transforming Innovation
In today’s technology-driven market, overlapping or similar patents are common, often exposing companies to the risk of patent litigation. Understanding global trends in patent litigation enables businesses to remain vigilant and competitive. As markets grow increasingly interconnected and acceleration in technological advancements, disputes related to patent are becoming more complex and broad. Therefore, analyzing the […]
- 1
- 2